Skip to main content

Biotalys announces participation at upcoming scientific, industry and investor events

Written by Customer Service on . Posted in Public Companies.

Ghent, BELGIUM , Sept. 26, 2023 (GLOBE NEWSWIRE) — Press release

Biotalys (Euronext – BTLS), an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for crop and food protection, today announces the participation of the company in a variety of upcoming events. Biotalys welcomes the opportunity to engage with the scientific community, industry, and investors during these events to share the company’s ongoing development of its pipeline and technology platform.

World Agri-Tech Innovation Summit
September 26-27, 2023
London, UK
Patrice Sellès, CEO of Biotalys, will participate in a panel discussion.

POLITICO The Future of Food and Agriculture Summit
September 28, 2023
Paris, France

Investor Access (event in French)
October 9-10, 2023
Paris, France

European Congress of Entomology
October 16-20, 2023
Heraklion, Greece

Conference on Recombinant Protein Production
October 17-19, 2023
Girona, Spain

ABIM Annual Biocontrol Industry Meeting
October 23-25, 2023
Basel, Switzerland
Including the award ceremony for Innovative Biocontrol Product of the Year, for which Biotalys’ first biofungicide, Evoca™*, has been nominated

Roth MKM AgTech Answers Conference
November 14, 2023
New York, NY, USA

Kepler Cheuvreux Global Agriculture Forum
November 16, 2023
Virtual

VFB Biotech Event (event in Dutch)
November 16, 2023
Ghent, Belgium

PEGS Europe Protein & Antibody Engineering Summit
November 14-16, 2023
Lisbon, Portugal

Cannacord Genuity AgriFood Tech Innovation Forum
November 30, 2023
Virtual

Biotalys Shareholders Club (event in Dutch)
December 12, 2023
Ghent, Belgium

* Evoca™: Pending Registration. This product is not currently registered for sale or use in the United States, the European Union, or elsewhere and is not being offered for sale.

About Biotalys

Biotalys is an Agricultural Technology (AgTech) company developing protein-based biocontrol solutions for the protection of crops and food and aiming to provide alternatives to conventional chemical pesticides for a more sustainable and safer food supply. Based on its novel AGROBODY™ technology platform, Biotalys is developing a strong and diverse pipeline of effective product candidates with a favorable safety profile that aim to address key crop pests and diseases across the whole value chain, from soil to plate. Biotalys was founded in 2013 as a spin-off from the VIB (Flanders Institute for Biotechnology) and has been listed on Euronext Brussels since July 2021. The company is based in the biotech cluster in Ghent, Belgium. More information can be found on www.biotalys.com.

For further information, please contact

Toon Musschoot, Head of IR & Communication
T: +32 (0)9 274 54 00
E: Toon.Musschoot@biotalys.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.